Humanized Mice Model Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Model Type (Genetic Humanized Mice Model, Cell-Based Humanized Mice Model); Application (Toxicology, Oncology, Infectious Diseases, GvHD, Regenerative Medicine, Neurobiology, Others); End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and geography

Report Code: TIPRE00018013 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

In order to increase the similarity to human metabolism, technological advances in humanised mice models include the introduction of human genetic material into mice and research into more numbers of human-specific infectious agents, representing an opportunity for existing market players. It is anticipated that the development of next-gen humanised mouse models will provide exciting opportunities to develop robust small animal models to study the pathogenesis of human-specific transferrable agents and to assess the effectiveness and toxicity of novel experimental vaccines and therapeutic agents.

MARKET DYNAMICS

Factors driving the growth of the humanized mice model market are the Increasing demand for more effective screening of new drug candidates discovered by the healthcare industry to treat a number of chronic diseases such as cardiovascular diseases, diabetes, and cancers, coupled with an emergence of new players due to the growing demand for better mouse models that are capable of overcoming the limitations of xenograft models. However, the high cost of vegetarian humanized mice model is expected to hamper the growth of the market. Moreover, rising demand for personalized medicine is anticipated to boost the market growth.

MARKET SCOPE

The "Humanized Mice Model Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of humanized mice model market with detailed market segmentation by model type, application and end user. The humanized mice model market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in humanized mice model market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The humanized mice model market is segmented on the basis of model type, application and end user. Based on model type, the market is segmented as genetic humanized mice model and cell-based humanized mice model. Cell-based humanized mice model is sub segmented as CD-34 and PBMC. On the basis of application, the market is categorized as toxicology, oncology, infectious diseases, GvHD, regenerative medicine, neurobiology, and others. On the basis of end user, the market is categorized as pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the humanized mice model market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The humanized mice model market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting humanized mice model market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the humanized mice model market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the humanized mice model market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from humanized mice model market are anticipated to have lucrative growth opportunities in the future with the rising demand for humanized mice model in the global market. Below mentioned is the list of few companies engaged in the humanized mice model market.

The report also includes the profiles of key players in humanized mice model market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Genoway S.A.
  •  Yecuris Corporation
  •  THE JACKSON LABORATORY
  •  Taconic Biosciences, Inc.
  •  Ingenious Targeting Laboratory Inc.
  •  orizon Discovery Group plc.
  •  Charles River Laboratories, Inc.
  •  Crown Bioscience Inc.
  •  HuMurine Technologies
  •  Trans Genic Inc., Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Humanized Mice Model Market - By Model Type
1.3.2 Humanized Mice Model Market - By Application
1.3.3 Humanized Mice Model Market - By End User
1.3.4 Humanized Mice Model Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMANIZED MICE MODEL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMANIZED MICE MODEL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMANIZED MICE MODEL MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMANIZED MICE MODEL - GLOBAL MARKET OVERVIEW
6.2. HUMANIZED MICE MODEL - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2027 - MODEL TYPE
7.1. OVERVIEW
7.2. MODEL TYPE MARKET FORECASTS AND ANALYSIS
7.3. GENETIC HUMANIZED MICE MODEL
7.3.1. Overview
7.3.2. Genetic Humanized Mice Model Market Forecast and Analysis
7.4. CELL-BASED HUMANIZED MICE MODEL
7.4.1. Overview
7.4.2. Cell-Based Humanized Mice Model Market Forecast and Analysis
7.4.3. CD-34 Market
7.4.3.1. Overview
7.4.3.2. CD-34 Market Forecast and Analysis
7.4.4. PBMC Market
7.4.4.1. Overview
7.4.4.2. PBMC Market Forecast and Analysis
8. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. TOXICOLOGY
8.3.1. Overview
8.3.2. Toxicology Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
8.5. INFECTIOUS DISEASES
8.5.1. Overview
8.5.2. Infectious Diseases Market Forecast and Analysis
8.6. GVHD
8.6.1. Overview
8.6.2. GvHD Market Forecast and Analysis
8.7. REGENERATIVE MEDICINE
8.7.1. Overview
8.7.2. Regenerative Medicine Market Forecast and Analysis
8.8. NEUROBIOLOGY
8.8.1. Overview
8.8.2. Neurobiology Market Forecast and Analysis
8.9. OTHERS
8.9.1. Overview
8.9.2. Others Market Forecast and Analysis
9. HUMANIZED MICE MODEL MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biotechnology Companies Market Forecast and Analysis
9.4. CONTRACT RESEARCH ORGANIZATIONS
9.4.1. Overview
9.4.2. Contract Research Organizations Market Forecast and Analysis
9.5. ACADEMIC AND RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academic and Research Institutes Market Forecast and Analysis
10. HUMANIZED MICE MODEL MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Humanized Mice Model Market Overview
10.1.2 North America Humanized Mice Model Market Forecasts and Analysis
10.1.3 North America Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.1.4 North America Humanized Mice Model Market Forecasts and Analysis - By Application
10.1.5 North America Humanized Mice Model Market Forecasts and Analysis - By End User
10.1.6 North America Humanized Mice Model Market Forecasts and Analysis - By Countries
10.1.6.1 United States Humanized Mice Model Market
10.1.6.1.1 United States Humanized Mice Model Market by Model Type
10.1.6.1.2 United States Humanized Mice Model Market by Application
10.1.6.1.3 United States Humanized Mice Model Market by End User
10.1.6.2 Canada Humanized Mice Model Market
10.1.6.2.1 Canada Humanized Mice Model Market by Model Type
10.1.6.2.2 Canada Humanized Mice Model Market by Application
10.1.6.2.3 Canada Humanized Mice Model Market by End User
10.1.6.3 Mexico Humanized Mice Model Market
10.1.6.3.1 Mexico Humanized Mice Model Market by Model Type
10.1.6.3.2 Mexico Humanized Mice Model Market by Application
10.1.6.3.3 Mexico Humanized Mice Model Market by End User
10.2. EUROPE
10.2.1 Europe Humanized Mice Model Market Overview
10.2.2 Europe Humanized Mice Model Market Forecasts and Analysis
10.2.3 Europe Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.2.4 Europe Humanized Mice Model Market Forecasts and Analysis - By Application
10.2.5 Europe Humanized Mice Model Market Forecasts and Analysis - By End User
10.2.6 Europe Humanized Mice Model Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Humanized Mice Model Market
10.2.6.1.1 Germany Humanized Mice Model Market by Model Type
10.2.6.1.2 Germany Humanized Mice Model Market by Application
10.2.6.1.3 Germany Humanized Mice Model Market by End User
10.2.6.2 France Humanized Mice Model Market
10.2.6.2.1 France Humanized Mice Model Market by Model Type
10.2.6.2.2 France Humanized Mice Model Market by Application
10.2.6.2.3 France Humanized Mice Model Market by End User
10.2.6.3 Italy Humanized Mice Model Market
10.2.6.3.1 Italy Humanized Mice Model Market by Model Type
10.2.6.3.2 Italy Humanized Mice Model Market by Application
10.2.6.3.3 Italy Humanized Mice Model Market by End User
10.2.6.4 Spain Humanized Mice Model Market
10.2.6.4.1 Spain Humanized Mice Model Market by Model Type
10.2.6.4.2 Spain Humanized Mice Model Market by Application
10.2.6.4.3 Spain Humanized Mice Model Market by End User
10.2.6.5 United Kingdom Humanized Mice Model Market
10.2.6.5.1 United Kingdom Humanized Mice Model Market by Model Type
10.2.6.5.2 United Kingdom Humanized Mice Model Market by Application
10.2.6.5.3 United Kingdom Humanized Mice Model Market by End User
10.2.6.6 Rest of Europe Humanized Mice Model Market
10.2.6.6.1 Rest of Europe Humanized Mice Model Market by Model Type
10.2.6.6.2 Rest of Europe Humanized Mice Model Market by Application
10.2.6.6.3 Rest of Europe Humanized Mice Model Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Humanized Mice Model Market Overview
10.3.2 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis
10.3.3 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.3.4 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Humanized Mice Model Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Humanized Mice Model Market
10.3.6.1.1 Australia Humanized Mice Model Market by Model Type
10.3.6.1.2 Australia Humanized Mice Model Market by Application
10.3.6.1.3 Australia Humanized Mice Model Market by End User
10.3.6.2 China Humanized Mice Model Market
10.3.6.2.1 China Humanized Mice Model Market by Model Type
10.3.6.2.2 China Humanized Mice Model Market by Application
10.3.6.2.3 China Humanized Mice Model Market by End User
10.3.6.3 India Humanized Mice Model Market
10.3.6.3.1 India Humanized Mice Model Market by Model Type
10.3.6.3.2 India Humanized Mice Model Market by Application
10.3.6.3.3 India Humanized Mice Model Market by End User
10.3.6.4 Japan Humanized Mice Model Market
10.3.6.4.1 Japan Humanized Mice Model Market by Model Type
10.3.6.4.2 Japan Humanized Mice Model Market by Application
10.3.6.4.3 Japan Humanized Mice Model Market by End User
10.3.6.5 South Korea Humanized Mice Model Market
10.3.6.5.1 South Korea Humanized Mice Model Market by Model Type
10.3.6.5.2 South Korea Humanized Mice Model Market by Application
10.3.6.5.3 South Korea Humanized Mice Model Market by End User
10.3.6.6 Rest of Asia-Pacific Humanized Mice Model Market
10.3.6.6.1 Rest of Asia-Pacific Humanized Mice Model Market by Model Type
10.3.6.6.2 Rest of Asia-Pacific Humanized Mice Model Market by Application
10.3.6.6.3 Rest of Asia-Pacific Humanized Mice Model Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Humanized Mice Model Market Overview
10.4.2 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis
10.4.3 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.4.4 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Humanized Mice Model Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Humanized Mice Model Market
10.4.6.1.1 South Africa Humanized Mice Model Market by Model Type
10.4.6.1.2 South Africa Humanized Mice Model Market by Application
10.4.6.1.3 South Africa Humanized Mice Model Market by End User
10.4.6.2 Saudi Arabia Humanized Mice Model Market
10.4.6.2.1 Saudi Arabia Humanized Mice Model Market by Model Type
10.4.6.2.2 Saudi Arabia Humanized Mice Model Market by Application
10.4.6.2.3 Saudi Arabia Humanized Mice Model Market by End User
10.4.6.3 U.A.E Humanized Mice Model Market
10.4.6.3.1 U.A.E Humanized Mice Model Market by Model Type
10.4.6.3.2 U.A.E Humanized Mice Model Market by Application
10.4.6.3.3 U.A.E Humanized Mice Model Market by End User
10.4.6.4 Rest of Middle East and Africa Humanized Mice Model Market
10.4.6.4.1 Rest of Middle East and Africa Humanized Mice Model Market by Model Type
10.4.6.4.2 Rest of Middle East and Africa Humanized Mice Model Market by Application
10.4.6.4.3 Rest of Middle East and Africa Humanized Mice Model Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Humanized Mice Model Market Overview
10.5.2 South and Central America Humanized Mice Model Market Forecasts and Analysis
10.5.3 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Model Type
10.5.4 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Application
10.5.5 South and Central America Humanized Mice Model Market Forecasts and Analysis - By End User
10.5.6 South and Central America Humanized Mice Model Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Humanized Mice Model Market
10.5.6.1.1 Brazil Humanized Mice Model Market by Model Type
10.5.6.1.2 Brazil Humanized Mice Model Market by Application
10.5.6.1.3 Brazil Humanized Mice Model Market by End User
10.5.6.2 Argentina Humanized Mice Model Market
10.5.6.2.1 Argentina Humanized Mice Model Market by Model Type
10.5.6.2.2 Argentina Humanized Mice Model Market by Application
10.5.6.2.3 Argentina Humanized Mice Model Market by End User
10.5.6.3 Rest of South and Central America Humanized Mice Model Market
10.5.6.3.1 Rest of South and Central America Humanized Mice Model Market by Model Type
10.5.6.3.2 Rest of South and Central America Humanized Mice Model Market by Application
10.5.6.3.3 Rest of South and Central America Humanized Mice Model Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMANIZED MICE MODEL MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HUMANIZED MICE MODEL MARKET, KEY COMPANY PROFILES
13.1. GENOWAY S.A.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. YECURIS CORPORATION
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THE JACKSON LABORATORY
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TACONIC BIOSCIENCES, INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. INGENIOUS TARGETING LABORATORY INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ORIZON DISCOVERY GROUP PLC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CHARLES RIVER LABORATORIES, INC.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. CROWN BIOSCIENCE INC.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. HUMURINE TECHNOLOGIES
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. TRANS GENIC INC., LTD.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Genoway S.A.
2. Yecuris Corporation
3. THE JACKSON LABORATORY
4. Taconic Biosciences, Inc.
5. Ingenious Targeting Laboratory Inc.
6. orizon Discovery Group plc.
7. Charles River Laboratories, Inc.
8. Crown Bioscience Inc.
9. HuMurine Technologies
10. Trans Genic Inc., Ltd.
TIPRE00018013
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking